The Syqe Inhaler is the company’s flagship product utilizing its innovative technology. The company has completed several successful clinical trials that demonstrated the ability to provide predictable, precise and consistent bioavailability. Unlike traditional inhalers, Syqe’s breakthrough drug delivery technology introduces precision electronic dose control and inspiration automation, ensuring programmable consistent pharmacokinetics.

Pulmonary drug delivery offers several potential clinical advantages. It allows for lower doses of drug to be administered than needed in oral drug delivery, typically leading to a reduction in toxicity and fewer adverse events. Inhalation can also provide faster onset of action when compared to an oral route of administration.

The Syqe device was designed for the administration of pharmaceuticals and medicinal plants which are contained in a unique cartridge. The cartridge contains VaporChips, pre-loaded with a precise and uniform amount of medicinal material. The inhaler delivers an individually tailored precise dosage for the daily treatment regime of each patient. The inhaler is simple and friendly to use and can be used unobtrusively.